This announcement contains
inside information for the purposes of Regulation 11 of the Market
Abuse (Amendment) (EU Exit) Regulations 2019/310. With the
publication of this announcement, this information is now
considered to be in the public domain.
18
December 2024
Biome Technologies
plc
("Biome", the "Company" or
the "Group")
Secured Funding
Facility
Further to the Company's
announcement on 4 December 2024, Biome Technologies plc, a leading
bioplastics and radio frequency technology business, announces that
the Company has agreed the terms of a £750,000 secured funding loan
facility to provide working capital for the Group (the
"Secured Funding
Facility").
​
Background to and reasons for the Secured Funding
Facility
On 4 December 2024, the Company
announced, inter alia,
that internal completion dates for two large RF projects,
originally expected to be completed in 2024, had been revised into
Q1 2025, which had created a requirement for additional working
capital in the absence of which the Company would be unable to meet
its liabilities as they fall due. The Company, having had the offer
of this Secured Funding Facility, discussed working capital
sourcing with a range of external providers but concluded that no
external providers were able to offer better terms nor the
flexibility or timeliness provided by the Secured Funding
Facility.
The Secured Funding Facility has
been provided by the Company's Non-Executive Directors who are also
substantial shareholders. The Secured Funding Facility will
enable the Company, across its divisions, to navigate the period
through to completion of the RF contracts.
Although no requirement for further
drawdowns is currently anticipated, the facility contemplates the
potential for subsequent additional tranches of up to £1,000,000 in
aggregate on terms as may be agreed at the time by the Company and
the lenders.
Details of the Secured
Funding Facility
· The
Company has entered the Secured Funding Facility by which a total
of £750,000 will be made available to the Company by Martin
Rushton-Turner and Brian Geary (together the "Lenders") in equal amounts.
· It is
expected that the first drawdown from the Secured Funding Facility
will be before the end of December 2024 and in an amount of
£350,000, with further drawdowns from the available balance of the
Secured Funding Facility likely in the first half of
2025.
· The
Secured Funding Facility will be secured by debentures creating
fixed and floating security which will be entered into by the
Company and each of its material subsidiaries. Security will
be held by a security trustee on behalf of the Lenders.
· The
aggregate drawings under the Secured Funding Facility are
contemplated to be repaid by final stage payments under a number of
contracts entered into by the Company's subsidiary, Stanelco RF
Technologies Limited. Work remains to complete those
contracts, following which customer acceptance and invoicing is
anticipated. Stage payments when invoiced will be paid into a
segregated bank account and applied in repayment of the Secured
Funding Facility.
· It is
expected that the Secured Funding Facility will be repaid in full
out of the above-mentioned stage payments during the first half of
2025. The Secured Funding Facility provides for full repayment by
no later than 30 November 2025.
· Interest is not payable on the Secured Funding Facility other
than on amounts outstanding from 1 June 2025 and from which date a
fixed rate of interest of 10% per cent per annum will
accrue.
· A
Signing Fee is payable to the Lenders in relation to the Secured
Funding Facility in the amount of £225,000, irrespective of the
amount that is drawn down. The signing fee will be apportioned as
to £123,750 to Mr Rushton-Turner and £101,250 to Mr Geary. Costs
from the Security Trustee of £3,625 plus VAT will also be paid by
the Company.
· Drawing fees are payable to the Lenders in relation to the
Secured Funding Facility in the amount of 20% of any drawn
amount. This would equate to £150,000 if the Secured Funding
Facility was fully drawn. The drawing fees will be apportioned to
Mr Rushton-Turner and Mr Geary on an equal basis.
· The
above fees are payable only on the earliest of: (i) 30 November
2025, (ii) the date of any equity capital raise by the Company or
any of its subsidiaries, and (iii) such other date as may be agreed
between the Company and the Lenders.
· The
Secured Funding Facility contains alternative settlement
arrangements, whereby in the event that the Company or one of its
subsidiaries raises equity capital, each Lender may elect to have
some or all of his participation in loans, interest and fees repaid
by way of the issue of Biome new ordinary shares to it (at a 25%
discount to the price of relevant new ordinary shares issued as
part of any such equity capital raise) instead of receiving
cash.
· The
Secured Funding Facility contains customary representations,
undertakings and events of default. If an event of default
occurs, the Lenders will be entitled to require early repayment in
full of the Secured Funding Facility.
· The
Company has agreed that it will not repay the Secured Funding
Facility early except out of the stage payments referred to above,
unless its internal cash flow projections indicate that it will
have, during 2025, a cash balance greater than currently
expected.
· Most
amendments to the Secured Funding Facility will be permitted with
the consent of the Company and a majority of Lenders, although a
limited number of amendments will require the consent of all
Lenders.
· Commitments in respect of the Secured Funding Facility may not
be transferred to any person who is not already a Lender without
the Company's good faith reasonable consent, unless an event of
default has occurred in which case commitments are freely
transferrable.
· To
build in additional flexibility using the same Secured Funding
Facility documentation and structure, the facility agreement
contemplates that additional tranches of up to £1,000,000 in
aggregate may be provided. However, there is no commitment on the
part of the Lenders to offer, or of the Company to solicit or seek,
any such additional amounts and none are currently contemplated.
Furthermore, the terms of such additional tranches would be subject
to mutual agreement between the Lenders and the Company.
Related party
transactions
Mr John Martin Rushton-Turner and Mr
Brian Geary are providing up to £375,000 each of the Secured
Funding Facility respectively. As Mr Rushton-Turner and Mr Geary
each currently hold more than 10 per cent. of the Ordinary Shares
and are both directors of the Company, entering into the Secured
Funding Facility is deemed to be a related party transaction
pursuant to rule 13 of the AIM Rules for Companies. Paul Mines
considers, having consulted with the Company's nominated adviser,
Allenby Capital, that the terms of the Secured Funding Facility are
fair and reasonable insofar as Shareholders are
concerned.
-Ends-
For
further information please contact:
|
Biome Technologies plc
Paul Mines, Chief Executive
Officer
|
Donna Simpson-Strange, Company
Secretary
|
www.biometechnologiesplc.com
|
Tel: +44 (0) 2380 867 100
|
Allenby Capital
|
David Hart/Alex Brearley/Lauren
Wright (Nominated Adviser)
Kelly Gardiner/Tony Quirke (Sales
and Corporate Broking)
|
www.allenbycapital.com
|
Tel: +44 (0) 20 3328 5656
|
About Biome
Biome Technologies plc is an AIM
listed, growth-orientated, commercially driven technology group.
Our strategy is founded on building market-leading positions based
on patented technology and serving international customers in
valuable market sectors. We have chosen to do this by developing
products in application areas where the value-added pricing can be
justified and are not reliant on government legislation. These
products are driven by customer requirements and are compatible
with existing manufacturing processes. They are market rather than
technology-led.
The Group comprises two divisions,
Biome Bioplastics ("Bioplastics") and Stanelco RF Technologies
Limited ("RF Technologies").
Biome Bioplastics is a leading
developer of highly-functional, bio-based and biodegradable
plastics. The division's mission is to produce bioplastics that
challenge the dominance of oil- based polymers.
RF Technologies designs, builds and
services advanced radio frequency (RF) systems. Dielectric and
induction heating products are at the core of a product offering
that ranges from portable sealing devices to large furnaces for the
fibre optics markets.
www.biometechnologiesplc.com
www.biomebioplastics.com
and www.thinkbioplastic.com
www.stanelcorftechnologies.com